Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_assertion type Assertion NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_head.
- NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_provenance.
- NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_assertion evidence source_evidence_literature NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_provenance.
- NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_assertion SIO_000772 22593176 NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_provenance.
- NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_assertion wasDerivedFrom befree-20150227 NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_provenance.
- NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_assertion wasGeneratedBy ECO_0000203 NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_provenance.